
Bitglim M 2mg/500mg Tablet
Marketer
Elicad Pharmacueticals Pvt Ltd
Salt Composition
Glimepiride (2mg) + Metformin (500mg)
Overview Bitglim M 2mg/500mg Tablet
Diabetax Duo 2mg/500mg tablets are classified as antidiabetic medications, combining two active ingredients to manage type 2 diabetes in adults. This formulation aids in regulating blood glucose levels. Diabetax Duo should be ingested with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can lead to elevated glucose levels, increasing the risk of complications such as kidney impairment, vision loss, neuropathy, and limb amputation. Remember, this medication is part of a comprehensive diabetes management plan encompassing a balanced diet, regular physical activity, and weight management as advised by your doctor. Lifestyle modifications are vital for successful diabetes control. Hypoglycemia (low blood sugar) is a common side effect; familiarize yourself with its symptoms (sweating, dizziness, headache, tremors) and treatment. Maintain regular mealtimes and carry a fast-acting glucose source, like sugary snacks or juice. Alcohol consumption should be limited due to increased hypoglycemia risk. Additional possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Individuals with a history of heart disease should inform their doctor before initiating treatment. Pregnant or breastfeeding women require medical consultation prior to use. Regular blood glucose monitoring is necessary, and your doctor may order blood tests to track blood cell counts and liver function.
Uses of Bitglim M 2mg/500mg Tablet
Managing type 2 diabetes
Major Benefits of Bitglim M 2mg/500mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the Bitglim M 2mg/500mg tablet whole; avoid chewing, crushing, or fracturing it. Consume with a meal.
Common Side effects of Bitglim M 2mg/500mg Tablet:
- Headache
- Hypoglycemia (low blood glucose level)
- Nausea
- Diarrhea
How to use Bitglim M 2mg/500mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Bitglim M 2mg/500mg Tablet should be administered with a meal.
How Bitglim M 2mg/500mg Tablet works:
Each Bitglim M 2mg/500mg tablet unites glimepiride (2mg) and metformin (500mg), two antidiabetic agents. Glimepiride, a sulfonylurea, enhances pancreatic insulin secretion, thus reducing blood glucose. Metformin, a biguanide, acts triply: decreasing hepatic glucose output, slowing intestinal glucose uptake, and improving insulin responsiveness.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Bitglim M 2mg/500mg Tablet is not advised due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
Using Bitglim M 2mg/500mg tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the potential advantages against these risks prior to prescribing. Physician consultation is advised.
Breast feedingUNSAFE
Administering Bitglim M 2mg/500mg tablets while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should use Bitglim M 2mg/500mg tablets cautiously, potentially requiring dosage modification. Physician consultation is recommended. Bitglim M 2mg/500mg tablets are contraindicated in patients with severe kidney disease. Regular kidney function monitoring is advised during treatment.
LiverCAUTION
Patients with liver impairment should use Bitglim M 2mg/500mg tablets cautiously, potentially requiring dosage modification. Consult your physician for guidance. A reduced initial dose is typically recommended for individuals with mild to moderate hepatic dysfunction; the medication is contraindicated in those with severe liver disease.
What if you forget to take Bitglim M 2mg/500mg Tablet :
Should you forget a Bitglim M 2mg/500mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Bitglim M 2mg/500mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
